Clément Larrue

3.4k total citations
23 papers, 788 citations indexed

About

Clément Larrue is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Clément Larrue has authored 23 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 16 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Clément Larrue's work include Acute Myeloid Leukemia Research (18 papers), Protein Degradation and Inhibitors (6 papers) and Autophagy in Disease and Therapy (6 papers). Clément Larrue is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Protein Degradation and Inhibitors (6 papers) and Autophagy in Disease and Therapy (6 papers). Clément Larrue collaborates with scholars based in France, United States and Switzerland. Clément Larrue's co-authors include Estelle Saland, Christian Récher, Stéphane Manenti, Jean Emmanuel Sarry, François Vergez, Jérôme Tamburini, Éric Delabesse, Sarah Bertoli, Carine Joffre and Jean‐Emmanuel Sarry and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Clément Larrue

22 papers receiving 784 citations

Peers

Countries citing papers authored by Clément Larrue

Since Specialization

Citations

This map shows the geographic impact of Clément Larrue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clément Larrue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clément Larrue more than expected).

Fields of papers citing papers by Clément Larrue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clément Larrue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clément Larrue. The network helps show where Clément Larrue may publish in the future.

Co-authorship network of co-authors of Clément Larrue

This figure shows the co-authorship network connecting the top 25 collaborators of Clément Larrue. A scholar is included among the top collaborators of Clément Larrue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clément Larrue. Clément Larrue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia 2024 ·Blood Advances ·Clément Larrue, Sarah Mouche, Jérôme Tamburini	1
2	Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models 2024 ·Science Translational Medicine ·Clément Larrue, Sarah Mouche, Paolo Angelino, (unknown), Rudy Birsen, Olivier Kosmider, Thomas McKee, François Vergez, Christian Récher, Véronique Mansat‐De Mas, Qiong Gu, Jun Xu, Petros Tsantoulis, Jean-Emmanuel Sarry, Jérôme Tamburini	11
3	Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia 2023 ·Blood Advances ·Jérôme Tamburini, Sarah Mouche, Clément Larrue, Nicolas Duployez, Audrey Bidet, (unknown), Pierre Hirsch, (unknown), Sylvain Carras, Marie Templé, Fabrizia Favale, Pascale Flandrin‐Gresta, Yannick Le Bris, (unknown), Laurent Mauvieux, Sylvie Tondeur, Éric Delabesse, François Delhommeau, Pierre Sujobert, Olivier Kosmider	3
4	Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia 2023 ·Leukemia ·Clément Larrue, Sarah Mouche, Shan Lin, Federico Simonetta, (unknown), Laury Poulain, Rudy Birsen, Jean‐Emmanuel Sarry, Kimberly Stegmaier, Jérôme Tamburini	31
5	APR-246 induces early cell death by ferroptosis in acute myeloid leukemia 2021 ·Haematologica ·Rudy Birsen, Clément Larrue, Justine Decroocq, (unknown), (unknown), Mathilde Gotanègre, (unknown), Éric Grignano, (unknown), Michaëla Fontenay, Olivier Kosmider, Patrick Mayeux, Nicolas Chapuis, Jean Emmanuel Sarry, Jérôme Tamburini, Didier Bouscary	131
6	AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia 2021 ·Cancers ·(unknown), Amandine Pradier, Laury Poulain, Sarah Mouche, Rudy Birsen, Clément Larrue, Federico Simonetta, Jérôme Tamburini	2
7	Inhibition of the proteasome and proteaphagy enhances apoptosis in FLT3‐ITD‐driven acute myeloid leukemia 2020 ·FEBS Open Bio ·(unknown), (unknown), (unknown), Clément Larrue, Jean‐Emmanuel Sarry, Manuel S. Rodríguez	7
8	Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo 2020 ·Cancers ·Nizar Serhan, Pierre‐Luc Mouchel, Philippe de Médina, Grégory Segala, (unknown), Estelle Saland, Arnaud Rives, Antonin Lamazière, Gaëtan Després, Jean‐Emmanuel Sarry, Clément Larrue, François Vergez, Laëtitia Largeaud, Michel Record, Christian Récher, Sandrine Silvente‐Poirot, Marc Poirot	16
9	Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia 2019 ·Cancer Research ·Mohsen Hosseini, Hamid Rezvani, Nesrine Aroua, Claudie Bosc, Thomas Farge, Estelle Saland, Veronique Guyonnet‐Dupérat, Sonia Zaghdoudi, (unknown), Clément Larrue, Marie Sabatier, Pierre‐Luc Mouchel, Mathilde Gotanègre, Marc Piechaczyk, Guillaume Bossis, Christian Récher, Jean‐Emmanuel Sarry	48
10	Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia 2019 ·Oncogenesis ·Clément Larrue, (unknown), Estelle Saland, Héléna Boutzen, Tony Kaoma, Jean‐Emmanuel Sarry, Carine Joffre, Christian Récher	25
11	Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia 2018 ·European Journal Of Haematology ·Sarah Bertoli, Étienne Paubelle, Emilie Bérard, Estelle Saland, Xavier Thomas, Suzanne Tavitian, (unknown), François Vergez, Éric Delabesse, Audrey Sarry, Françoise Huguet, Clément Larrue, Claudie Bosc, Thomas Farge, Jean Emmanuel Sarry, Mauricette Michallet, Christian Récher	69
12	Dexamethasone in hyperleukocytic acute myeloid leukemia 2018 ·Haematologica ·Sarah Bertoli, Muriel Picard, Emilie Bérard, Emmanuel Griessinger, Clément Larrue, Pierre‐Luc Mouchel, François Vergez, Suzanne Tavitian, (unknown), (unknown), Éric Delabesse, Isabelle Luquet, Laëtitia K. Linares, Estelle Saland, Martin Carroll, Gwenn Danet-Desnoyers, Audrey Sarry, Françoise Huguet, Jean Emmanuel Sarry, Christian Récher	42
13	Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia 2017 ·Oncogene ·(unknown), Clément Larrue, Estelle Saland, Sarah Bertoli, (unknown), Arnaud Besson, Stéphane Manenti, Carine Joffre, Véronique Mansat‐De Mas	82
14	Dexamethasone Reduces Incidence of Relapse and Improves Overall Survival in Hyperleucocytic Acute Myeloid Leukemia 2016 ·Blood ·Christian Récher, Sarah Bertoli, Muriel Picard, Emilie Bérard, Clément Larrue, Suzanne Tavitian, François Vergez, (unknown), (unknown), Éric Delabesse, Isabelle Luquet, Laëtitia K. Linares, Martin Carroll, Audrey Sarry, Françoise Huguet, Jean‐Emmanuel Sarry	2
15	CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia 2015 ·Oncotarget ·Sarah Bertoli, Héléna Boutzen, (unknown), Clément Larrue, François Vergez, Anne Fernandez-Vidal, (unknown), Jérôme Tamburini, Cécile Demur, Éric Delabesse, Estelle Saland, Jean‐Emmanuel Sarry, (unknown), Véronique Mansat‐De Mas, Christine Didier, Christine Dozier, Christian Récher, Stéphane Manenti	21
16	Antileukemic Activity of 2-Deoxy- d -Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations 2015 ·Molecular Cancer Therapeutics ·Clément Larrue, Estelle Saland, François Vergez, Nizar Serhan, Éric Delabesse, (unknown), Jérôme Tamburini, Stéphane Manenti, Jean Emmanuel Sarry, Christian Récher	61
17	A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia 2015 ·Blood Cancer Journal ·Estelle Saland, Héléna Boutzen, Rémy Castellano, Laurent Pouyet, Emmanuel Griessinger, Clément Larrue, Fabienne de Toni, Sarah Scotland, Marion David, (unknown), François Vergez, Yara Barreira, Yves Collette, Christian Récher, (unknown)	55
18	Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells 2015 ·Blood ·Clément Larrue, Estelle Saland, Héléna Boutzen, François Vergez, Marion David, Carine Joffre, Jérôme Tamburini, Éric Delabesse, Stéphane Manenti, Jean Emmanuel Sarry, Christian Récher	103
19	The Combination of ATRA and Dasatinib for Differentiation Therapy in Acute Myeloid Leukemias with IDH Mutations 2015 ·Blood ·Héléna Boutzen, Estelle Saland, (unknown), Clément Larrue, Thomas Farge, Nizar Serhan, Fabienne de Toni, Marion David, Lara Gales, Florence Castelli, Christophe Junot, Éric Delabesse, (unknown), Jean‐Charles Portais, Ouathek Ouerfelli, Guangli Yang, François Vergez, Christian Récher, Jean‐Emmanuel Sarry	3
20	The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors 2012 ·Leukemia ·(unknown), Clément Larrue, François Vergez, Jean‐Emmanuel Sarry, Sarah Bertoli, Véronique Mansat‐De Mas, Cécile Demur, Éric Delabesse, Bernard Payrastre, Stéphane Manenti, Serge Roche, Christian Récher	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact